How Hyperglycemia and Hypoglycemia Disrupt the Menstrual Cycle via Hormonal Interference

Glucose dysregulation perturbs the hypothalamic-pituitary-ovarian (HPO) axis:

Hyperglycemia / Insulin Resistance (T2D, PCOS)

  • Hyperinsulinemia → ovarian theca cell androgen overproduction → anovulation, oligomenorrhea.
  • Insulin ↓ hepatic SHBG → ↑ free testosterone.
  • Inflammation/oxidative stress → impaired follicular development.
  • Associated obesity → leptin dysregulation → GnRH disruption.

Hypoglycemia (Insulin-treated T1D/T2D)

  • Counterregulatory surge: glucagon, epinephrine, cortisol, GH.
  • Cortisol ↑ → inhibits GnRH pulsatility → anovulation.
  • Recurrent hypoglycemia → HPA axis dysregulation → menstrual irregularity.
  • Autonomic neuropathy → impaired hypoglycemia awareness → vicious cycle.

Management

  • Glycemic targets individualized (HbA1c <6.5–7% preconception; <7% general).
  • CGM + pump/MDI with automated insulin delivery reduces variability.
  • Weight loss (5–10%) restores ovulation in many PCOS/T2D.
  • Preconception counseling essential.

Endocrinologist + OB/GYN coordination optimizes reproductive and metabolic outcomes.

Diabetes - Related Articles